Red Blood Cell Biomarker May Aid in Diagnosis of Early Alzheimer Disease

Red Blood Cell Biomarker May Aid in Diagnosis of Early Alzheimer Disease
LOS ANGELES — The level of α-syn heteroaggregates in red blood cells (RBCs) may be a tool for the diagnostic work-up of early Alzheimer disease (AD), according to study results presented at the Annual Scientific Meeting of the Alzheimer’s Association International Conference 2019, held July 14-18 in Los Angeles, California. The study included patients with early-stage AD with prodromal symptoms ... read more
Source: Neurology AdvisorPublished on 2019-07-23By Hannah Dellabella